2026 Agenda

Most international patient businesses are leaving a 10X opportunity on the table, not because they lack patients, but because they've never been shown how distribution actually works. In this session, Jonathan Edelheit dismantles the playbook that built insurance empires, dominated real estate, and scaled SaaS — and shows exactly how it maps to medical tourism right now. You'll see how paying partners faster compounds loyalty and volume, how one referral relationship can multiply into a thousand through multi-tier distribution, and how any hospital, clinic, or facilitator can launch a full outbound BD engine without a single new hire. This isn't theory. Every lever is live and turnkey through Better by MTA. Come ready to take notes — the playbook you'll leave with is built for Monday morning.

Welcome to the industry's most importantclosed-door gathering. Jonathan Edelheit sets the stage for two days of high-impact sessions, strategic partnerships, and the conversations that will define the direction of global healthcare for the year ahead.

The rules of global healthcare are being rewritten — and the executives in this room are the ones writing them.

‍Governments are building national strategies around medical travel. Global insurers are being forced to rethink cross-border coverage from the ground up. Multinational employers are quietly becoming some of the most powerful buyers in international healthcare. And ultra-high-net-worth patients are demanding bespoke models that don't yet fully exist. The infrastructure holding all of it back — fragmentation, financing gaps, broken patient journeys — is finally meeting its match in a new wave of platforms, partnerships, and payment innovation. This executive fireside brings together the payer, payments, platform, and accreditation leaders who are actively dismantling the old model and building what comes next. If you want to understand where the biggest opportunities will sit in the next 3–5 years — and position yourself to capture them — this is the conversation you can't afford to miss.

Longevity medicine just graduated from biohacker hobby to boardroom strategy — and the early movers are already pulling ahead.

‍The clinicians and program architects in this session aren't theorizing about the future of longevity. They're reversing biological age markers, deploying AI-driven diagnostics, and running regenerative therapies inside hospital-grade infrastructure — right now. For employers, the math is becoming impossible to ignore: healthier executives, lower long-term claims, and a workforce that actually performs. For insurers, the actuarial assumptions built around aging are quietly being challenged. For hospitals and longevity centers, accreditation is emerging as the single trust layer that makes all of it sellable to corporate buyers at scale. This session pulls back the curtain on what employers of 500+ are actually purchasing today, how insurers can reframe longevity as a claims reduction strategy rather than a luxury line item, and what the partnership models between accredited institutions and longevity centers look like in practice. The window to build this into your strategy before it becomes standard is still open — but not for long.

A handful of physicians and institutions have cracked the code on global medical reputation — and this is the only room where they'll tell you how.

There is a short list of names in global medicine that governments call when a head of state needs care, that insurers route their most complex cases to, and that patients cross continents to reach — without a single ad campaign. What separates them isn't just clinical excellence. It's the strategy, relationships, and institutional architecture behind programs that have been deliberately built to attract the world's highest-value patients and most demanding cases. For hospital systems and international patient programs, this session is a masterclass in what elite global positioning actually requires — and what it unlocks in volume, partnerships, and institutional credibility. For insurers and employers, it's a direct line to understanding how to identify, vet, and build preferred relationships with the providers your highest-cost, highest-need members are already seeking out on their own. You will not get this level of access in a panel format anywhere else. Come with your strategic questions ready.

The most dangerous assumption in global healthcare right now is that the conditions your program was built for will hold.

Patient corridors shift overnight. Referral patterns that took years to establish can dissolve in a single news cycle. The organizations that weather disruption — whether it's a pandemic, a regional conflict, an economic shock, or an airline crisis — aren't the ones that react fastest. They're the ones that built for it before it happened. This session delivers a practical resilience framework for international patient programs: how to diversify markets before you need to, how to maintain referral partner confidence when conditions deteriorate, and how to design operational systems that compress recovery time and protect program performance across cycles. For hospital systems, insurers, and employers with cross-border exposure, this is not a crisis management conversation. It is a competitive positioning one — because in an increasingly volatile global environment, program resilience is the infrastructure that determines who retains contracts, relationships, and volume when everything else is in flux.

The conversations that actually move this industry don't happen on stage — they happen when the right decision-makers are finally in the same room with nowhere to hide.

‍Roundtable Revolution is not a session you watch. It is one you shape. Six tables. Six of the most unresolved, high-stakes challenges facing global healthcare, medical travel, and cross-border insurance today — each anchored by a senior industry leader and populated with a deliberately engineered mix of hospital CEOs, insurers, employers, ministry officials, facilitators, and investors. The cross-sector collisions that happen here don't occur anywhere else on the agenda. In sixty minutes, you will have engaged directly with decision-makers you'd otherwise spend months trying to reach, pressure-tested your thinking against theirs, and contributed to a live industry position that doesn't get filtered, softened, or sanitized. The findings from every table are consolidated into the official post-summit intelligence brief — distributed globally and cited as the definitive pulse-check of the sector. For hospital systems, insurers, employers, and anyone with a stake in where this industry moves next, your presence at this table is not just valuable. It is the difference between influencing the outcome and reading about it afterward. Seats are limited. Attendance is by registration only. The next chapter of global healthcare gets written in this room — the only question is whether your voice is in it.

Two of the most powerful forces reshaping US employer healthcare are in this room — and they're telling you exactly where it's all heading.

‍Lee Lewis of the Health Transformation Alliance and Christine Hale of Gallagher don't advise on employer healthcare. They move it. Together they represent millions of covered lives and a level of purchasing influence that forces hospitals, insurers, and benefits innovators to respond. Lee is implementing strategies most employers haven't dared attempt yet, inside a system architecturally resistant to change. Christine operates at the highest-acuity end of the market — getting the most complex patients to the right institutions at the right moment, nationally. For hospital systems and international patient programs, this session is a direct signal of what the most sophisticated buyers in American healthcare are demanding — and what you need to be building toward to be in their networks. For insurers and benefits innovators, it's an unfiltered look at where employer expectations are moving before the rest of the market catches up. The decisions being made by rooms like this one determine which providers and solutions win the next decade. Listen accordingly.

In the new architecture of global healthcare, the providers winning institutional contracts aren't outspending competitors on marketing — they're outperforming them on proof.

‍The buyers reshaping international patient flow — self-funded employers, global insurers, government health ministries — are no longer moved by brochures, testimonials, or brand recognition alone. They are asking for outcomes data, accreditation standards, and performance reporting that holds up under procurement scrutiny. For hospital systems and international patient programs, this session is a direct blueprint for making the shift from opportunistic referrals to structured, long-term institutional contracts — the kind that create predictable volume, deeper payer relationships, and a defensible competitive position. For insurers and employers, it clarifies exactly what separates a provider worth contracting with from one still competing on price and proximity. Trust at this level of the market is not built through a campaign. It is built through the infrastructure of measurable, verifiable, repeatable performance — and the organizations that understand this earliest will own the relationships that define the next decade of global healthcare.

The hospitals winning in global healthcare aren't just delivering better outcomes — they're delivering experiences that make patients, partners, and payers unwilling to go anywhere else.

‍Clinical excellence is the entry ticket. It is no longer the differentiator. The institutions commanding premium positioning, deeper referral relationships, and the highest rates of repeat and referred international patients have done something most healthcare organizations haven't attempted: they have engineered the experience with the same intentionality that the world's most powerful brands apply to loyalty. For hospital systems and international patient programs, this session is a masterclass in transforming every touchpoint — from first inquiry to post-discharge follow-up — into a cohesive brand experience that builds confidence, commands premium perception, and turns patients and referral partners into active ambassadors. For insurers and employers, it reframes what a preferred provider relationship actually feels like at the institutional level — and why the organizations that invest in experience design retain contracts longer and generate more consistent volume. The gap between a hospital that is respected and one that is sought after comes down to this. And it is entirely buildable.

Behind every cross-border program that collapses, you'll find the same story: someone assumed the legal, insurance, and operational infrastructure was someone else's problem — until it wasn't.

‍Patients stranded abroad. Employers facing litigation. Partnerships unraveling under the weight of a single undocumented liability gap. The architecture holding a cross-border care program together is largely invisible — until it fails. This session makes it visible. A leading healthcare attorney, global insurance executives, and international medical assistance providers share the same stage to dismantle exactly how these three functions interlock — and where the fracture points are that most programs never see coming. For hospital systems and international patient programs, this is the session that stress-tests your current structure against the legal, coverage, and operational realities of what cross-border care actually demands. For insurers and employers, it is a direct briefing on what defensible program design looks like — jurisdiction, liability allocation, physician licensing, coverage architecture, and the ground-level execution that turns a referral into a recoverable outcome. Most cross-border programs aren't one bad clinical outcome away from failure. They're one undiscovered compliance gap away. This session shows you where to look before someone else finds it for you.Clinical excellence alone is no longer enough to differentiate in a competitive global market. Leading institutions intentionally design experiences that create emotional connection, confidence, and long-term loyalty among patients and partners. This session explores how hospitals can transform international programs into cohesive brand experiences through structured experience engineering, referral partner design, and consistent delivery that strengthens reputation, enhances retention, and turns patients and partners into long-term ambassadors.